You Own Wall Street › Funds › Janus Henderson Global Life Sciences Fund
Janus Henderson Global Life Sciences Fund (JAGLX) proxy voting record 2026
Three of its ballots from this season. Vote first, then see what it did with the shares your savings paid for.
The question on the ballot
As filed
Janus Investment Fund files this fund's proxy votes with the SEC once a year. This is what it did with the shares your retirement savings paid for.
SourceProxy-voting record filed by Janus Investment Fund on 2026-08-28 · open the filing · vote table (proxyvote.xml, 19 MB)
TickersJAGLX (Class T), JFNAX (Class A), JFNCX (Class C), JFNIX (Class I), JFNSX (Class S), JNGLX (Class D), JFNNX (Class N) · share classes of one fund, with one proxy-voting record · as listed in its latest SEC filing of proxy votes
How it voted, by issue
Fund companies sometimes file the same proposal under different subjects. So that funds can be compared, each proposal is counted under the subject most of the filings we read gave it, the same for every fund on this site. On management's own executive pay resolutions, this fund voted in favour 96.9% of the time across 65 votes.
| Issue | Proposals faced | Backed | Share backed |
|---|---|---|---|
| Climate & environment | 3 | 0 | 0% |
| Executive pay | 1 | 1 | 100% |
| Corporate governance | 12 | 9 | 75% |
| Other social issues | 5 | 0 | 0% |
Ballots it voted
Merck & Co., Inc. · 26 May 2026 · put on the ballot by shareholder · Climate & environment
Regarding a report on DEI risks in federal contracting.
AGAINST Janus Henderson Global Life Sciences Fund voted with 631,676 shares
“Shareholder proposal regarding a report on DEI risks in federal contracting.”
SourceJanus Investment Fund, Form N-PX filed 2026-08-28 · accession 0001193125-26-373338 · series S000010494 · open the filing
Merck & Co., Inc. · 26 May 2026 · put on the ballot by shareholder · Climate & environment
Regarding a report on healthcare coverage gaps.
AGAINST Janus Henderson Global Life Sciences Fund voted with 631,676 shares
“Shareholder proposal regarding a report on healthcare coverage gaps.”
SourceJanus Investment Fund, Form N-PX filed 2026-08-28 · accession 0001193125-26-373338 · series S000010494 · open the filing
Humana Inc. · 16 April 2026 · put on the ballot by shareholder · Executive pay
Should shareholders get a vote before Humana pays a departing executive?
Shareholders asked the company to seek shareholder approval for any severance package to a senior executive above a set multiple of salary and bonus — so that very large exit payments cannot be agreed by the board alone.
FOR Janus Henderson Global Life Sciences Fund voted with 52,533 shares
“The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting.”
SourceJanus Investment Fund, Form N-PX filed 2026-08-28 · accession 0001193125-26-373338 · series S000010494 · open the filing
Johnson & Johnson · 23 April 2026 · put on the ballot by shareholder
Should the person who runs Johnson & Johnson also chair the board that supervises them?
Shareholders asked the company to require that the chair of the board be an independent director rather than the chief executive, so that the body overseeing management is not led by the person being overseen.
FOR Janus Henderson Global Life Sciences Fund voted with 1,527,159 shares
“Independent Board Chair”
SourceJanus Investment Fund, Form N-PX filed 2026-08-28 · accession 0001193125-26-373338 · series S000010494 · open the filing
CVS Health Corporation · 14 May 2026 · put on the ballot by shareholder
Should CVS Health’s shareholders be able to act without waiting for a meeting?
Shareholders asked for the right to act by written consent — to approve a measure once holders of enough shares agree in writing, instead of waiting for the company to schedule a meeting.
AGAINST Janus Henderson Global Life Sciences Fund voted with 1,072,042 shares
“Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent.”
SourceJanus Investment Fund, Form N-PX filed 2026-08-28 · accession 0001193125-26-373338 · series S000010494 · open the filing
Merck & Co., Inc. · 26 May 2026 · put on the ballot by shareholder · Social
Should Merck disclose the politics its money pays for?
Shareholders asked the company to publish its political spending — direct contributions and money routed through trade associations and other third parties — and whether that spending matches the values the company states publicly.
AGAINST Janus Henderson Global Life Sciences Fund voted with 631,676 shares
“Shareholder proposal regarding a report on political contributions.”
SourceJanus Investment Fund, Form N-PX filed 2026-08-28 · accession 0001193125-26-373338 · series S000010494 · open the filing
Eli Lilly and Company · 4 May 2026 · put on the ballot by shareholder · Social
Should Eli Lilly and disclose what it lobbies for?
Shareholders asked for a report on the company’s lobbying: what it spends, which trade associations receive its money, what positions those bodies take, and who inside the company decides.
AGAINST Janus Henderson Global Life Sciences Fund voted with 489,794 shares
“Shareholder proposal to prepare an annual lobbying report.”
SourceJanus Investment Fund, Form N-PX filed 2026-08-28 · accession 0001193125-26-373338 · series S000010494 · open the filing
Other funds Janus Investment Fund votes
The same filer reports these alongside this one, in the same annual filing.
No 401(k) plan we index offers this fund. Its record is here because the fund files it with the SEC, as every fund must: whoever holds it, in an IRA, a brokerage account or a plan we have not indexed, the fund votes those shares as shown on this page.